Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

Trial Profile

Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Ulipristal (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Acronyms ellipse II
  • Sponsors HRA Pharma
  • Most Recent Events

    • 18 Sep 2014 One of the brands of study drug Ulipristal (ella one) deleted from protocol and trial title got changed, study status got changed from discontinued to recruiting, number of pt. got changed from 500 to 100, trial locations changed to only USA and Centers.
    • 22 Jan 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 13 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top